References
Müller JS, Mihaylova V, Abicht A, Lochmüller H. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission. Expert Rev Mol Med 2007;9: 1–20.
Thirion C, Lochmüller H. Current status of gene therapy for muscle diseases. Drug News Perspect 2007;20: 357–363.
Rifai Z, Welle S, Moxley RT, Lorenson M, Griggs RC. Effect of prednisone on protein metabolism in Duchenne dystrophy. Am J Physiol 1995;268: E67-E74.
Treatment of neuromuscular diseases. In: Griggs RC, Moxley RT, editors. Advances in neurology, vol. 17. New York: Raven Press; 1977.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lochmüller, H., Griggs, R.C. New treatments for neuromuscular disease: Optimism and obstacles. Neurotherapeutics 5, 497–498 (2008). https://doi.org/10.1016/j.nurt.2008.08.010
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.nurt.2008.08.010